LL

Louis Lucido

Director at BioCorRx

Louis Lucido was formerly the Senior Advisor and Chief Operating Officer of DoubleLine Group, LP, a large investment firm with over $100 billion in assets under management. He recently retired in December 2018 and was one of the five founding partners. He was previously at TCW, where he served as a Group Managing Director. Prior to joining TCW in 2001, Mr. Lucido was the Chief Investment Officer for Delphi Financial Group (DFG) and was on several subsidiary boards. Before DFG, he was the Chief Operating Officer and Secretary for Hyperion Capital Management and was also a member of the Resolution Trust Advisory Committee. Former Board Chair of CASALA, currently Treasurer, member of Executive Committee and Trustee of National CASA/GAL. Current member of the Board of Directors of the Lupus Research Alliance. Former board member for Junior Achievement of Southern California 826LA & 826 National. Mr. Lucido received his MBA in Management and Finance from New York University, and was a member of the Dean’s Advisory Board of the N.Y.U. Stern School of Business.


Org chart

This person is not in the org chart


Teams

This person is not in any teams


Offices

This person is not in any offices


BioCorRx

BioCorRx Pharmaceuticals is a subsidiary of BioCorRx Inc. (OTCQB: BICX). The company was envisioned and set up with the aim of providing new options for Medication-Assisted Treatment (MAT) for the treatment of substance use disorder.


Industries

Employees

1-10

Links